- £171.29m
- £822.89m
- £663.70m
- 35
- 79
- 67
- 66
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | R2023 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 842 | 797 | 338 | 377 | 664 |
Cost of Revenue | |||||
Gross Profit | 436 | 371 | 237 | 234 | 415 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 976 | 1,098 | 399 | 401 | 936 |
Operating Profit | -135 | -301 | -61.2 | -23.5 | -273 |
Net Income Before Taxes | -135 | -301 | -61.2 | -23.5 | -273 |
Provision for Income Taxes | |||||
Net Income After Taxes | -162 | -313 | -67.8 | -28 | -273 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -162 | -313 | -67.8 | -28 | -273 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -162 | -313 | -67.8 | -28 | -273 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.515 | -0.563 | -0.173 | -0.152 | -0.695 |
Dividends per Share |